RS
Ruby Singh Kahar
About Ruby Singh Kahar
Data last updated:
Ruby Singh Kahar is a Director at Provatas Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. Provatas Pharmaceuticals Private Limited reported revenue of ₹50.2 Lakh (FY 2025). Earlier, Ruby Singh Kahar was a Director at Novotas Biotech Private Limited (from 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Provatas Pharmaceuticals Private Limited U47721DL2023PTC413605 | Director | 04 May 2023 | 2023 | ₹50.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novotas Biotech Private Limited U24299PN2021PTC199414 | Director | 13 Mar 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ruby Singh Kahar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Geeta Prasad Kahar | 10147355 | Provatas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ruby Singh Kahar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruby Singh Kahar
Ruby Singh Kahar currently holds 1 directorship: Provatas Pharmaceuticals Private Limited (Director, since 04 May 2023, revenue ₹50.2 Lakh (FY 2025)).
Ruby Singh Kahar was first appointed on 13 Mar 2021 as Director at Novotas Biotech Private Limited. The most recent appointment on record is 04 May 2023 at Provatas Pharmaceuticals Private Limited.
Ruby Singh Kahar held 1 earlier board appointment: Novotas Biotech Private Limited (Director, from 13 Mar 2021).
The current boards of Ruby Singh Kahar's companies include Geeta Prasad Kahar (Provatas Pharmaceuticals Private Limited).